C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 31/7125 (2006.01) A61P 37/04 (2006.01) C07H 21/00 (2006.01)
Patent
CA 2381993
The invention provides methods for modulating the immune response caused by CpG-containing oligonucleotides. The methods according to the invention enables both decreasing the immunostimulatory effect for antisense applications, as well as increasing the immunostimulatory effect for immunotherapy applications.
L'invention concerne des méthodes de modulation de la réponse immunitaire provoquée par des oligonucléotides contenant des CpG. Les méthodes selon l'invention permettent à la fois de réduire l'effet immunostimulateur dans le cadre d'applications antisens, et d'accroître cet effet immunostimulateur dans le cadre d'applications d'immunothérapie.
Hybridon Inc.
Idera Pharmaceuticals Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Modulation of oligonucleotide cpg-mediated immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of oligonucleotide cpg-mediated immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of oligonucleotide cpg-mediated immune... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1804180